Page last updated: 2024-08-21

glycopyrrolate and td-4208

glycopyrrolate has been researched along with td-4208 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hegde, SS; Jaw-Tsai, S; Ji, Y; Martin, WJ; McNamara, A; Obedencio, GP; Pulido-Rios, MT	1

Other Studies

1 other study(ies) available for glycopyrrolate and td-4208

Article	Year
In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 346, Issue:2 Topics: Acetylcholine; Administration, Inhalation; Animals; Benzamides; Bronchoconstriction; Bronchodilator Agents; Carbamates; Dogs; Dose-Response Relationship, Drug; Glycopyrrolate; Lung; Male; Methacholine Chloride; Muscarinic Antagonists; Pilocarpine; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Salivation; Scopolamine Derivatives; Tiotropium Bromide	2013

Article

Year

In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models.

The Journal of pharmacology and experimental therapeutics, 2013, Volume: 346, Issue:2

Topics: Acetylcholine; Administration, Inhalation; Animals; Benzamides; Bronchoconstriction; Bronchodilator Agents; Carbamates; Dogs; Dose-Response Relationship, Drug; Glycopyrrolate; Lung; Male; Methacholine Chloride; Muscarinic Antagonists; Pilocarpine; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Salivation; Scopolamine Derivatives; Tiotropium Bromide

2013